Resource hubs

Resource hubs host a range of information on specific clinical areas. Items may contain pharmaceutical promotional information.

Resources (which contain promotional information) provided by Norgine.
View TARGAXAN ® (rifaximin-α) prescribing and adverse events reporting information
UK-HEP-XIF-2100027 Date of preparation: October 2021
  • Best practice in hepatic encephalopathy

  • Consensus statement: identification and management of hepatic encephalopathy